http://www.rockyradar.com/2009/07/23/miragen-and-archemix-announce-joint-development-agreement/2195 A RockyRadar Blog covering Colorado technology Wed, 28 Jul 2010 15:28:04 -0600 http://wordpress.org/?v=2.8.5 hourly 1 http://www.rockyradar.com/2009/07/23/miragen-and-archemix-announce-joint-development-agreement/2195/comment-page-1#comment-5736 CUBioX Fri, 24 Jul 2009 23:50:18 +0000 http://www.rockyradar.com/?p=2195#comment-5736 Since the advent of SELEX to isolate RNA aptamers was developed by Larry Gold, CU professor in Boulder, almost twenty years ago now, it good to see so many formidable uses of these aptamers coming about. The great thing about this collaboration is that each company is getting exactly what they need. miRagen needs to be able to deliver its miRNA therapies in vivo effectively to start clinical trials, and Archemix sees a potential way of harnessing its technology for gene regulation purposes and applying it to many diseases. I think this is great for miRagen and I'm glad to see that they will have the exclusive option of retaining the rights. Since the advent of SELEX to isolate RNA aptamers was developed by Larry Gold, CU professor in Boulder, almost twenty years ago now, it good to see so many formidable uses of these aptamers coming about. The great thing about this collaboration is that each company is getting exactly what they need. miRagen needs to be able to deliver its miRNA therapies in vivo effectively to start clinical trials, and Archemix sees a potential way of harnessing its technology for gene regulation purposes and applying it to many diseases. I think this is great for miRagen and I'm glad to see that they will have the exclusive option of retaining the rights.

]]>